Cite
HARVARD Citation
Pal, S. et al. (2017). A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 123 (4), pp. 576-582. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pal, S. et al. (2017). A phase 2 study of the sphingosine‐1‐phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 123 (4), pp. 576-582. [Online].